Suppr超能文献

Hippo-YAP 信号通路与生长接触抑制。

The Hippo-YAP signaling pathway and contact inhibition of growth.

机构信息

Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

出版信息

J Cell Sci. 2014 Feb 15;127(Pt 4):709-17. doi: 10.1242/jcs.140103.

Abstract

The Hippo-YAP pathway mediates the control of cell proliferation by contact inhibition as well as other attributes of the physical state of cells in tissues. Several mechanisms sense the spatial and physical organization of cells, and function through distinct upstream modules to stimulate Hippo-YAP signaling: adherens junction or cadherin-catenin complexes, epithelial polarity and tight junction complexes, the FAT-Dachsous morphogen pathway, as well as cell shape, actomyosin or mechanotransduction. Soluble extracellular factors also regulate Hippo pathway signaling, often inhibiting its activity. Indeed, the Hippo pathway mediates a reciprocal relationship between contact inhibition and mitogenic signaling. As a result, cells at the edges of a colony, a wound in a tissue or a tumor are more sensitive to ambient levels of growth factors and more likely to proliferate, migrate or differentiate through a YAP and/or TAZ-dependent process. Thus, the Hippo-YAP pathway senses and responds to the physical organization of cells in tissues and coordinates these physical cues with classic growth-factor-mediated signaling pathways. This Commentary is focused on the biological significance of Hippo-YAP signaling and how upstream regulatory modules of the pathway interact to produce biological outcomes.

摘要

Hippo-YAP 通路介导细胞增殖的控制,包括细胞在组织中的接触抑制以及其他物理状态属性。几种机制可以感知细胞的空间和物理组织,并通过不同的上游模块发挥作用,刺激 Hippo-YAP 信号通路:黏着连接或钙黏着蛋白-catenin 复合物、上皮极性和紧密连接复合物、FAT-Dachsous 形态发生途径,以及细胞形状、肌动球蛋白或机械转导。可溶性细胞外因子也调节 Hippo 通路信号,通常抑制其活性。事实上,Hippo 通路介导了接触抑制和有丝分裂信号之间的一种相互关系。因此,在菌落边缘、组织中的伤口或肿瘤中的细胞对环境水平的生长因子更为敏感,并且更有可能通过 YAP 和/或 TAZ 依赖性过程增殖、迁移或分化。因此,Hippo-YAP 通路感知和响应组织中细胞的物理组织,并将这些物理线索与经典的生长因子介导的信号通路相协调。本评论集中讨论了 Hippo-YAP 信号的生物学意义,以及该通路的上游调节模块如何相互作用以产生生物学结果。

相似文献

1
The Hippo-YAP signaling pathway and contact inhibition of growth.
J Cell Sci. 2014 Feb 15;127(Pt 4):709-17. doi: 10.1242/jcs.140103.
2
E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5. doi: 10.1073/pnas.1103345108. Epub 2011 Jul 5.
3
Regulation of YAP/TAZ Activity by Mechanical Cues: An Experimental Overview.
Methods Mol Biol. 2019;1893:183-202. doi: 10.1007/978-1-4939-8910-2_15.
4
Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Small GTPases. 2020 Jul;11(4):280-288. doi: 10.1080/21541248.2018.1435986. Epub 2018 Apr 20.
5
Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2569-74. doi: 10.1073/pnas.1216462110. Epub 2013 Jan 28.
6
Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules.
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1785-90. doi: 10.1073/pnas.1420850112. Epub 2015 Jan 26.
7
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Genes Dev. 2011 Jan 1;25(1):51-63. doi: 10.1101/gad.2000111.
8
Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
Cell. 2012 Aug 17;150(4):780-91. doi: 10.1016/j.cell.2012.06.037. Epub 2012 Aug 2.
9
The Hippo Signaling Network and Its Biological Functions.
Annu Rev Genet. 2018 Nov 23;52:65-87. doi: 10.1146/annurev-genet-120417-031621. Epub 2018 Sep 5.
10
DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
PLoS One. 2017 Jan 6;12(1):e0169587. doi: 10.1371/journal.pone.0169587. eCollection 2017.

引用本文的文献

2
Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis.
PLoS Comput Biol. 2025 Apr 15;21(4):e1012298. doi: 10.1371/journal.pcbi.1012298. eCollection 2025 Apr.
3
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications.
Mol Biol Rep. 2025 Feb 27;52(1):267. doi: 10.1007/s11033-025-10372-y.
4
The IGF2BP1 oncogene is a druggable mA-dependent enhancer of YAP1-driven gene expression in ovarian cancer.
NAR Cancer. 2025 Feb 24;7(1):zcaf006. doi: 10.1093/narcan/zcaf006. eCollection 2025 Mar.
5
Cadherins and growth factor receptors - ligand-selective mechano-switches at cadherin junctions.
J Cell Sci. 2025 Feb 1;138(3). doi: 10.1242/jcs.262279. Epub 2025 Feb 17.
6
In Vitro Models of Cardiovascular Disease: Embryoid Bodies, Organoids and Everything in Between.
Biomedicines. 2024 Nov 27;12(12):2714. doi: 10.3390/biomedicines12122714.
7
Clinical Potential of Misshapen/NIKs-Related Kinase (MINK) 1-A Many-Sided Element of Cell Physiology and Pathology.
Curr Issues Mol Biol. 2024 Dec 5;46(12):13811-13845. doi: 10.3390/cimb46120826.
8
The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.
Int J Mol Sci. 2024 Nov 29;25(23):12868. doi: 10.3390/ijms252312868.
9
On the control of cell proliferation.
Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2420807121. doi: 10.1073/pnas.2420807121. Epub 2024 Dec 2.

本文引用的文献

2
Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.
Cell. 2013 Sep 12;154(6):1342-55. doi: 10.1016/j.cell.2013.08.025. Epub 2013 Sep 5.
3
Opposite feedbacks in the Hippo pathway for growth control and neural fate.
Science. 2013 Oct 11;342(6155):1238016. doi: 10.1126/science.1238016. Epub 2013 Aug 29.
4
A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.
Cell. 2013 Aug 29;154(5):1047-1059. doi: 10.1016/j.cell.2013.07.042. Epub 2013 Aug 15.
5
Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos.
Curr Biol. 2013 Jul 8;23(13):1181-94. doi: 10.1016/j.cub.2013.05.014. Epub 2013 Jun 20.
6
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
Genes Dev. 2013 Jun 1;27(11):1223-32. doi: 10.1101/gad.219402.113.
7
cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
EMBO J. 2013 May 29;32(11):1543-55. doi: 10.1038/emboj.2013.102. Epub 2013 May 3.
8
An evolutionary shift in the regulation of the Hippo pathway between mice and flies.
Oncogene. 2014 Mar 6;33(10):1218-28. doi: 10.1038/onc.2013.82. Epub 2013 Apr 8.
9
Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.
Dev Cell. 2013 Mar 11;24(5):459-71. doi: 10.1016/j.devcel.2013.01.020.
10
The Hippo pathway and human cancer.
Nat Rev Cancer. 2013 Apr;13(4):246-57. doi: 10.1038/nrc3458. Epub 2013 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验